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Liang-Dan Sun1,2,3, Min Gao1,2,3, Tian-Wen Gao5, Xing-Hua Gao6, Hong-Duo Chen6, Hong-Fu Xie7,
Cai-Xia Tu8, Fei Hao9, Ri-Na Wu10, Fu-Ren Zhang11, Ling Liang12, Xiong-Ming Pu13, Jian-Zhong Zhang14,
Jian-Wen Han10, Gong-Pu Pan3, Jia-Qiang Wu15, Kai Li5, Ming-Wan Su16, Wei-Dong Du3,
Wei-Jia Zhang3,17, Jian-Jun Liu3, Lei-Hong Xiang15, Sen Yang1,2,3, You-Wen Zhou3,16 and Xue-Jun Zhang1,2,3,15
To identify susceptibility loci for vitiligo, we extended our previous vitiligo genome-wide association study
with a two-staged replication study that included 6,857 cases and 12,025 controls from the Chinese Han popu-
lation. We identified three susceptibility loci, 12q13.2 (rs10876864, Pcombined¼ 8.07 1012, odds ratio (OR)¼ 1.18),
11q23.3 (rs638893, Pcombined¼ 2.47 109, OR¼ 1.22), and 10q22.1 (rs1417210, Pcombined¼ 1.83 108, OR¼ 0.88), and
confirmed three previously reported loci for vitiligo, 3q28 (rs9851967, Pcombined¼ 8.57 108, OR¼ 0.88), 10p15.1
(rs3134883, Pcombined¼ 1.01 105, OR¼ 1.11), and 22q12.3 (rs2051582, Pcombined¼ 2.12 105, OR¼ 1.14), in the
Chinese Han population. The most significant single-nucleotide polymorphism in the 12q13.2 locus is located
immediately upstream of the promoter region of PMEL, which encodes a major melanocyte antigen and has
expression loss in the vitiligo lesional skin. In addition, both 12q13.2 and 11q23.3 loci identified in this study are
also associated with other autoimmune diseases such as type 1 diabetes and systemic lupus erythematosus. These
findings provide indirect support that vitiligo pathogenesis involves a complex interplay between immune
regulatory factors and melanocyte-specific factors. They also highlight similarities and differences in the genetic
basis of vitiligo in Chinese and Caucasian populations.
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INTRODUCTION
Vitiligo is an autoimmune disease presenting with progressive
loss of skin pigmentation affecting about 1% of individuals in
most populations worldwide (Le Poole and Luiten, 2008).
Generalized vitiligo is an acquired, noncontagious disorder
characterized by progressive, patchy loss of pigmentation
of skin, and often overlying hair and mucous membranes,
resulting from loss of melanocytes in the affected areas
(Spritz, 2007). Clinical and epidemiological investigations
indicated that vitiligo might follow a pattern of polygenetic
or multifactorial inheritance (Alkhateeb et al., 2003; Zhang
et al., 2004). Many repigmentation therapies, such as
steroids and UV irradiation, are immunosuppressive
and the beneficial effect of such treatments supports
the involvement of autoimmunity in vitiligo. Association
between vitiligo and other autoimmune diseases also
& 2013 The Society for Investigative Dermatology www.jidonline.org 403
ORIGINAL ARTICLE
Received 25 April 2012; revised 17 July 2012; accepted 20 July 2012; published online 6 September 2012
1Department of Dermatology and Venereology, Anhui Medical University, Hefei, China; 2Institute of Dermatology and Department of Dermatology at No.1
Hospital, Anhui Medical University, Hefei, China; 3State Key Laboratory Incubation Base of Dermatology, Ministry of National Science and Technology, Anhui,
China; 4Department of Dermatology, The Third People’s Hospital of Hangzhou, Hangzhou, China; 5Department of Dermatology, Xijing Hospital, Fourth
Military Medical University, Xi’an, China; 6Department of Dermatology, No.1 Hospital of China Medical University, Shenyang, China; 7Department of
Dermatology, Xiangya Hospital, Central South University, Changsha, China; 8Department of Dermatology, The 2nd Affiliated Hospital of Dalian Medical
University, Dalian, China; 9Department of Dermatology, Southwest Hospital, Third Military Medical University, Chongqing, China; 10Department of
Dermatology, The Affiliated Hospital of Inner Mongolia Medical College, Huhehot, China; 11Department of Dermatology, Shandong Provincial Institute of
Dermatology and Venereology, Jinan, China; 12Department of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China;
13Department of Dermatology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumchi, China; 14Department of Dermatology, Peking University
People’s Hospital, Beijing, China; 15Department of Dermatology, Huashan Hospital of Fudan University, Shanghai, China; 16Department of Dermatology and
Skin Science, University of British Columbia, Vancouver, British Columbia, Canada and 17Department of Medicine, Mount Sinai School of Medicine, New York,
New York, USA
Correspondence: Lei-Hong Xiang, Department of Dermatology, Huashan Hospital of Fudan University, 12 Urumqizhong Road, Shanghai, China.
E-mail: flora_xiang@vip.163.com or You-Wen Zhou, Department of Dermatology and Skin Science, University of British Columbia, 835 West 10th Ave,
Vancouver, British Columbia V5Z 4E8, Canada. E-mail: Youwen.Zhou@vch.ca or Xue-Jun Zhang, Institute of Dermatology, Anhui Medical University,
81 Meishan Road, Hefei, Anhui 230032, China. E-mail: ayzxj@vip.sina.com
18These authors contributed equally to this work.
Abbreviations: GWAS, genome-wide association study; LD, linkage disequilibrium; OR, odds ratio; SNP, single-nucleotide polymorphism
supports the role of autoimmunity of the disease (Jin et al.,
2010a).
To date, a number of genetic susceptibility factors
have been identified through linkage and association studies
(Chen et al., 2005; Ren et al., 2009; Spritz, 2011); however,
only a few genes/loci, such as NALP1 (Jin et al., 2007) and
some HLA alleles (Zamani et al., 2001; Arcos-Burgos et al.,
2002), have been consistently replicated in multiple studies.
Notably, several recent genome-wide association studies
(GWASs) of vitiligo in the Caucasian population have
identified a number of susceptibility genes/loci (Jin et al.,
2010a, 2010b, 2012), such as 1p13.2 (PTPN22), 1p36.23
(RERE), 2q24.2 (IFIH1), 3p13 (FOXP1), 3q13.33 (CD80),
3q28 (LPP), 6p21.3 (HLA-A), 6q27 (CCR6), 10p15.1 (IL2RA),
11p13 (CD44), 11q14.3 (TYR), 12q24.12 (SH2B3), 12q13.2
(IKZF4), 14q12 (GZMB), 16q24.3 (MC1R), 21q22.3 (UBA-
SH3A), 22q13.1 (C1QTNF6), and 22q13.2 (TOB2). In the
Chinese population, the identified susceptibility genes/loci
included 6p21.33 (HLA-B and HLA-C), 6q27 (RNASET2,
FGFR1OP, and CCR6), and 10q22.3 (ZMIZ1) (Quan et al.,
2010). Most of these loci encode immune-related proteins
and several have been associated with other autoimmune
diseases, highlighting common immune pathogenetic path-
ways underlying these different disorders.
In this study, to identify additional susceptibility loci for
vitiligo, we expanded our previous vitiligo GWAS (Quan
et al., 2010), increasing the power of both the genome-wide
discovery stage and subsequent replication stage by adding
272 healthy controls to the previous genome-wide screening
stage for a total of 1,117 cases and 1,701 controls, with
replication in two independent cohorts (replication 1: 2,827
cases and 3,876 controls; replication 2: 2,913 cases and
6,448 controls; Table 1). In addition, we conducted gene
expression studies on the genes implicated in the loci
identified in the current study and the genes implicated in
previous vitiligo GWASs to provide additional information on
the genes implicated in vitiligo genetic pathogenesis.
RESULTS AND DISCUSSION
Our GWAS data set consisted of 620,901 single-nucleotide
polymorphisms (SNPs) and copy number variant probes
genotyped in 1,117 cases and 1,701 controls in the current
study. After quality control, the genotype data of 493,909
autosomal SNPs in 1,117 cases and 1,701 controls were used
for association testing (Figure 1a). The quantile–quantile
(Q–Q) plots of the logarithms of our genome-wide P-values,
after removal of 4,031 SNPs from the major histocompat-
ibility complex region (6p21: 25–34Mb), largely fit the null
distribution, except at the tail of the distribution (Figure 1b).
Principal component analysis indicated that the cases and
controls were genetically matched (Supplementary Figure S1
online), and a moderate genomic inflation factor of lgc¼1.07
indicated minimal overall population stratification.
We employed three strategies for selecting SNPs (see
Materials and Methods). In total, 50 SNPs at 44 loci were
selected for the replication testing (replication 1: 2,827 cases
and 3,876 controls) (Supplementary Table S1 and S3–5
online). After applying standard quality control procedures,
the 13 most significant of the 50 SNPs (Preplication 1o0.05)
were further genotyped in a second independent replication
cohort (replication 2: 2,913 cases and 6,448 controls)
(Supplementary Table S5 online). These analyses identified
three loci, 12q13.2 (rs10876864, Pcombined¼8.07 1012,
odds ratio (OR)¼1.18), 11q23.3 (rs638893, Pcombined¼
2.47109, OR¼ 1.22), and 10q22.1 (rs1417210,
Pcombined¼1.83 108, OR¼0.88), reaching genome-wide
significance in the combined analysis of the GWAS and two
replication samples (Table 2). In addition, we also confirmed
three previously reported vitiligo susceptibility loci, 3q28
(rs9851967 and rs13076312), 10p15.1 (rs3134883), and
22q12.3 (rs2051582), with suggestive evidence of association
(8.57108 pPcombined p2.12105, Table 2). Results for
the other tested SNPs are summarized in Supplementary
Table S5 online.
Rs10876864, the most strongly associated SNP at the
12q13.2 locus, is located in a linkage disequilibrium (LD)
block that contains multiple genes (Figure 2a). It has strong
LD with the reported SNP rs1701704 (r2¼ 0.94 in the
CHBþ JPT panel) that is located upstream of IKZF4 (encoding
a zinc-finger transcription factor of T-cell activation, which is
a critical coregulator of FoxP3-directed gene silencing during
CD4þ regulatory T-cell differentiation (Pan et al., 2009)) in
previous type 1 diabetes (Hakonarson et al., 2008), alopecia
areata (Petukhova et al., 2010), and vitiligo (Jin et al., 2012)
studies. Interestingly, the associated SNP rs10876864 is
located 40 kb centromeric to PMEL, which encodes a
melanocyte protein necessary for eumelanin deposition 1 in
mammals (McGlinchey et al., 2009). It is shown that the
antigen-specific CD8þ T cells exhibit reactivity to modified
PMEL peptide epitopes in HLA-A2-positive vitiligo patients,
Table 1. Sample summary information for the GWAS and replication studies
Cases Controls
Analysis Population Sample size Mean age (SD) Male/female Sample size Mean age (SD) Male/female
GWAS Chinese Han 1,117 28.73 (±15.00) 656/461 1,701 35.9 (±14.81) 928/773
Replication 1 Chinese Han 2,827 26.91 (±14.35) 1,438/1,389 3,876 28.43 (±10.44) 1,890/1,986
Replication 2 Chinese Han 2,913 28.25 (±14.82) 1,564/1,349 6,448 29.39 (±15.86) 3,283/3,165
Total 6,857 27.36 (±14.54) 3,658/3,199 12,025 30.33 (±14.51) 6,101/5,924
Abbreviation: GWAS, genome-wide association study.
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which also supports the notion that there is a cell-mediated
immunopathologic mechanism in vitiligo (Mandelcorn-
Monson et al., 2003). By skin biopsy transcriptome analysis,
PMEL was shown to have the strongest differential expression
between vitiligo lesional skin and vitiligo perilesional normal
skin, with a 5.94-fold decrease in PMEL expression in lesional
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Figure 1. Genome-wide association results from the initial genome-wide association study (GWAS) analysis. (a) The genome-wide P-values of the
Cochran–Armitage trend test from 493,909 polymorphic single-nucleotide polymorphisms (SNPs) in 1,117 vitiligo cases and 1,701 controls of the Chinese
Han ancestry are presented. The chromosomal distribution of all the P-values (log10 P-values) is shown. (b) Quantile–quantile (Q–Q) plots of the observed
P-values for association. The gray line is for null expectation. The plot in purple is for P-values for SNPs excluding the 4,031 SNPs within the major
histocompatibility complex (MHC) region (6p21: 25–34Mb).
Table 2. Association evidence for seven SNPs at six loci in the GWAS, the replication studies, and the combined
analysis in the Chinese Han population
GWAS
Replication
study 1
Replication
study 2
Combined
Chinese Han
1,117 cases,
1,701 controls
2,827 cases,
3,876 controls
2,913 cases,
6,448 controls
6,857 cases,
12,025 controls
MAF OR P 1 MAF OR P 1 MAF OR P 1 OR (95% CI) P 1
SNP Chr Allele Case Control Case Control Case Control Gene
Identified loci
rs10876864 12q13.2 G 0.29 0.25 1.21 1.62E03 0.26 0.23 1.17 8.55E05 0.27 0.24 1.18 2.52E06 1.18 (1.13–1.24) 8.07E12 Multiple genes
rs638893 11q23.3 C 0.13 0.10 1.31 1.40E03 0.13 0.11 1.23 1.38E04 0.13 0.11 1.18 7.12E04 1.22 (1.14–1.30) 2.47E09 CXCR5/DDX6
rs1417210 10q22.1 C 0.27 0.32 0.78 4.04E05 0.29 0.32 0.87 3.01E04 0.29 0.31 0.91 8.56E03 0.88 (0.84–0.92) 1.83E08 SLC29A3/CDH23
Confirmed known loci
rs9851967 3q28 T 0.26 0.31 0.81 4.93E04 0.26 0.29 0.87 5.98E04 0.27 0.28 0.91 8.08E03 0.88 (0.84–0.92) 8.57E08 LPP
rs13076312 3q28 C 0.32 0.37 0.81 2.28E04 0.32 0.34 0.92 3.58E02 0.32 0.34 0.92 1.52E02 0.90 (0.86–0.94) 9.37E06 LPP
rs3134883 10p15.1 T 0.32 0.29 1.16 1.58E02 0.30 0.28 1.09 2.76E02 0.31 0.28 1.11 2.34E03 1.11 (1.06–1.16) 1.01E05 IL2RA
rs2051582 22q12.3 A 0.17 0.14 1.24 4.52E03 0.16 0.14 1.14 8.85E03 0.16 0.15 1.10 2.74E02 1.14 (1.07–1.21) 2.12E05 IL2RB
Abbreviations: Chr, chromosome; CI, confidence interval; GWAS, genome-wide association study; MAF, minor allele frequency; OR, odds ratio;
SNP, single-nucleotide polymorphism.
1Two-tailed P-values from the Cochran–Armitage trend test.
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skin compared with perilesional normal skin (PBonferroni¼
2.91106, Table 3). It has been postulated that PMEL might
have an important role in the structural organization of
premelanosomes, suggesting its potential role in the patho-
genesis of vitiligo.
It is intriguing that two other genes encoding major
melanocyte antigens, TYR and OCA2, have been strongly
implicated in vitiligo GWAS in the Caucasian population
(Jin et al., 2010a, 2012). Both genes also showed strong
expression loss in the lesional skin of vitiligo (Table 3).
Interestingly, neither of these genes emerges in the studies on
the Chinese population. Thus, there appears to be a
difference between the Caucasians and Chinese with respect
to the melanocyte-specific antigens involved in the patho-
genesis of vitiligo, although further studies are needed to
elucidate this apparent difference.
SNP rs638893 at 11q23.3 was located in an intergenic
region between DDX6 and CXCR5 (Figure 2b). It has weak
LD with the reported SNPs rs4639966 (r2¼0.10 in the
CHBþ JPT panel) and rs10892279 (r2¼0.38 in the
CHBþ JPT panel) near the DDX6 gene in previous systemic
lupus erythematosus, celiac disease, and rheumatoid arthritis
studies (Han et al., 2009; Zhernakova et al., 2011). DDX6
encodes a member of the DEAD box protein family, which is
an RNA helicase found in P-bodies and stress granules and
functions in translation suppression and mRNA degradation
(Weston and Sommerville, 2006). For this locus, another
candidate gene CXCR5 encodes the receptor for CXC-
chemokine ligand 13, a chemokine that is secreted by
CXCR5 follicular stromal cells. A defining molecule for T cells
with follicular-homing capability which are specialized for
providing help to germinal center B cells during antibody
responses to T-cell–independent antigens. CXCR5 has been
shown to have an important role in the pathogenesis of
autoimmunity (Vinuesa et al., 2005; Morita et al., 2011).
The associated SNP rs1417210 at 10q22.1 is located in an
LD block that contains SLC29A3 and CDH23 (Figure 2c).
According to the Chinese and Japanese data from the 1000
Genome Project, one nonsynonymous SNP rs2252996 in
SLC29A3 (G-A, V239I) has moderate LD (r2¼ 0.60) with
rs1417210, and further imputation analysis revealed the
stronger association at rs2252996 (Pimputed¼2.33 105
using GWAS sample) than at rs1417210 (PGWAS¼
4.04105). SLC29A3 encodes the equilibrative nucleoside
transporter hENT3, and mutations in SLC29A3 have been
found to be associated with the H syndrome, which can
include cutaneous hyperpigmentation (Molho-Pessach et al.,
2008). It is likely that the causal variant alters SLC29A3
gene functions through other mechanisms. Another candidate
gene of interest, CDH23, belongs to a member of the
cadherin superfamily, which encodes calcium-dependent
cell–cell adhesion glycoproteins.
Of the four previously reported vitiligo susceptibility loci
analyzed in our study, two loci, 3q28 (LPP) and 10p15.1
(IL2RA), were confirmed in the Chinese Han population
(Table 2, Supplementary Figure S2a and S2b online).
However, we did not observe significant associations for
the SNPs rs830605 at 3p13 and rs5756546 at 22q13.1 in the
Chinese Han population (Pcombined40.04, Supplementary
Table S6 online). Interestingly, we observed an associated
signal on 22q12.3 (rs2051582, Table 2). SNP rs2051582
resides between IL2RB (22q12.3) and C1QTNF6 (22q13.1)
(Supplementary Figure S2c online). IL2RB has been found to
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Figure 2. Association scatter plots for three susceptibility loci. According to
the genome-wide single-marker association analysis using the Cochran–
Armitage trend test, the P-values of single-nucleotide polymorphisms (SNPs)
(shown as log10 values in y-axis) were plotted against their map positions
(x-axis). The color of each SNP spot reflects its r2 with the top SNP (large red
diamond) within each association locus, changing from red to white.
Estimated recombination rates (based on the combined CHB and JPT samples
from the HapMap project) were plotted in light blue. Gene annotations were
adapted from the University of California Santa Cruz Genome Browser
(http://genome.ucsc.edu/). (a) 12q13.2, (b) 11q23.3, and (c) 10q22.1.
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Table 3. Lesional expression changes of genes located in the six loci in this study and the genes implicated in
previous vitiligo GWASs
Cyto-band Population Gene symbol Vit LS Vit NS Ratio (LS/NS) P* P** Reference
3q28 CHI LPP 2,254 2,314 0.97 0.80 40.05 Current study
10p15.1 CHI IL2RA 131 56 2.32 0.22 40.05 Current study
10p15.1 CHI RBM17 9,622 9,439 1.02 0.53 40.05 Current study
10p15.1 CHI PFKFB3 4,132 4,992 0.83 0.01 40.05 Current study
10q21.2 CHI SLC16A9 154 157 0.98 0.92 40.05 Current study
10q21.2 CHI CCDC6 35,834 33,542 1.07 0.05 40.05 Current study
10q21.2 CHI ANK3 16,578 16,567 1.00 0.99 40.05 Current study
10q21.2 CHI CDC2 1,260 960 1.31 0.00 40.05 Current study
10q21.2 CHI TMEM26 24 25 0.96 0.63 40.05 Current study
10q22.1 CHI UNC5B 6,983 10,419 0.67 0.01 40.05 Current study
10q22.1 CHI SLC29A3 312 309 1.01 0.90 40.05 Current study
10q22.1 CHI CDH23 117 139 0.84 0.35 40.05 Current study
11q23.3 CHI PHLDB1 622 812 0.77 0.00 40.05 Current study
11q23.3 CHI TREH 22 23 0.94 0.18 40.05 Current study
11q23.3 CHI AK021715 3,082 3,592 0.86 0.01 40.05 Current study
11q23.3 CHI DDX6 853 794 1.07 0.26 40.05 Current study
12q13.2 CHI DGKA 1,689 1,893 0.89 0.08 40.05 Current study
12q13.2 CHI PMEL 2,556 15,178 0.17 7.09E11 2.91E06 Current study
12q13.2 CHI CDK2 163 199 0.82 0.00 40.05 Current study
12q13.2 CHI RAB5B 2,429 2,644 0.92 0.07 40.05 Current study
12q13.2 CHI SUOX 354 459 0.77 0.01 40.05 Current study
12q13.2 CHI ZNFN1A4 714 518 1.38 0.00 40.05 Current study
12q13.2 CHI RPS26 136,513 131,924 1.03 0.12 40.05 Current study
12q13.2 CHI ERBB3 4,520 5,062 0.89 0.07 40.05 Current study
12q13.2 CHI PA2G4 7,964 7,329 1.09 0.04 40.05 Current study
22q13.1 CHI IL2RB 897 891 1.01 0.95 40.05 Current study
1p13.2 CAU PTPN22 67 65 1.01 0.91 40.05 Jin et al. (2010a)
1p36.23 CAU RERE 640 645 0.99 0.76 40.05 Jin et al. (2010a)
2q24.2 CAU IFIH1 2,133 1,989 1.07 0.22 40.05 Jin et al. (2012)
3p13 CAU FOXP1 13,893 14,408 0.97 0.32 40.05 Jin et al. (2010b)
3q13.33 CAU CD80 29 22 1.27 0.00 40.05 Jin et al. (2012)
6p21.32 CAU C6orf10 22 18 1.12 0.20 40.05 Jin et al. (2011)
6p21.32 CAU BTNL2 207 191 1.11 0.06 40.05 Jin et al. (2011)
6p21.32 CAU HLA-DRA 24,168 26,279 0.90 0.22 40.05 Jin et al. (2010a)
6p21.32 CAU HLA-DQA1 3,251 3,553 0.80 0.04 40.05 Jin et al. (2010a)
6p21.33 CHI HLA-C 180,807 200,667 0.91 0.19 40.05 Quan et al. (2010)
6p21.33 CHI HLA-B 87,298 113,152 0.76 0.00 40.05 Quan et al. (2010)
6p22.1 CAU HLA-A 29,884 37,321 0.80 0.00 40.05 Jin et al. (2010a)
6p22.1 CAU HCG9 23 22 1.02 0.86 40.05 Jin et al. (2010a)
6q15 CAU BACH2 477 490 0.97 0.61 40.05 Jin et al. (2012)
6q27 CHI and CAU CCR6 341 275 1.05 0.76 40.05 Jin et al., 2010b;
Quan et al., 2010
6q27 CHI RNASET2 6,585 6,503 1.00 1.00 40.05 Quan et al. (2010)
Table 3 continued on following page
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be associated with rheumatoid arthritis in the Caucasian
population (Eleftherohorinou et al., 2011). C1QTNF6 has
been shown to be associated with other autoimmune diseases
including vitiligo (Jin et al., 2010a). The three confirmed loci
(3q28, 10p15.1, and 22q12.3) in this study have clearly
supported the existence of common disease susceptibility for
vitiligo between the Chinese and Caucasian populations.
Using the restricted maximum likelihood method
(Yang et al., 2010), we estimated that the six loci explained
nearly 1% of the overall variance in disease risk. GWASs,
which have generally focused on common SNPs, have been
completed for most complex diseases. However, the causal
SNPs may lie within a much larger region than the LD block
surrounding the associated common SNPs (Cirulli and
Goldstein, 2010). Thus, it is speculated that the gene(s)
located in the adjacent LD block may also be potential
candidate one(s) for diseases. Therefore, further efforts (fine
mapping and functional study) are needed to determine the
causal gene(s) within each locus for vitiligo.
In summary, we conducted an extended GWAS on
vitiligo in the Chinese Han population and identified
three disease susceptibility loci and also confirmed three
previously reported loci. A melanocyte-specific antigen-
encoding gene, PMEL, might be implicated in the patho-
genesis of vitiligo in the Chinese population. Not only does
this observation indirectly support the pathogenic signifi-
cance of immunological interaction between the immune-
regulating genes and the melanocyte-specific genes in vitiligo
development, but it also provides further evidence that
population-specific differences exist between the Caucasian
and Chinese populations in the genetic predisposition to
vitiligo.
MATERIALS AND METHODS
Subjects
All samples were recruited from the Chinese Han population through
collaboration with multiple hospitals in China (Quan et al., 2010).
The clinical diagnosis of each patient was confirmed by at least
two dermatologists according to the diagnostic criteria of Vitiligo
European Task Force (Taieb and Picardo, 2007). We collected
clinical information from the subjects through a full clinical
checkup, and additional demographic information from both the
cases and controls was obtained through a structured questionnaire
as used previously (Quan et al., 2010). A written informed consent
was obtained from all participants. The study protocol was approved
by the Ethics Committee of the Anhui Medical University and was
conducted according to the Declaration of Helsinki principles.
SNP selection for replication
We adopted three approaches to select SNPs for replication. First,
after excluding previously reported vitiligo risk alleles and all SNPs
within the extended major histocompatibility complex region (6p21:
25–34Mb), we selected SNP(s) at each locus that showed suggestive
association (Pinitialo1 104) after stringent quality control proce-
dures. We selected the 19 most strongly associated SNPs at 15 loci
for replication testing (Supplementary Table S1 online). Second, we
searched the published GWAS on other autoimmune diseases
from the GWAS catalog (including ankylosing spondylitis, amyo-
trophic lateral sclerosis, type 1 diabetes , inflammatory bowel
disease, rheumatoid arthritis, multiple sclerosis, psoriasis, systemic
Table 3. Continued
Cyto-band Population Gene symbol Vit LS Vit NS Ratio (LS/NS) P* P** Reference
6q27 CHI FGFR1OP 822 621 1.34 0.00 40.05 Quan et al. (2010)
6q27 CAU SMOC2 13,074 17,624 0.84 0.11 40.05 Birlea et al. (2010)
8q24.22 CAU SLA 5,403 4,969 1.06 0.49 40.05 Jin et al. (2012)
10q22 CHI ZMIZ1 9,422 8,289 1.12 0.00 40.05 Quan et al. (2010)
10q25.3 CAU CASP7 4,678 4,418 1.04 0.50 40.05 Jin et al. (2012)
11p13 CAU CD44 44,395 43,993 1.01 0.81 40.05 Jin et al. (2012)
11q14.3 CAU TYR 232 6,691 0.02 2.96E09 1.21E04 Jin et al. (2010a)
12q13.2 CAU IKZF4 699 513 1.34 0.00 40.05 Jin et al. (2012)
12q24.12 CAU SH2B3 320 381 0.85 0.02 40.05 Jin et al. (2012)
14q12 CAU GZMB 593 485 1.18 0.40 40.05 Jin et al. (2010a)
15q12-13.1 CAU OCA2 440 1,246 0.35 1.84E07 7.54E03 Jin et al. (2012)
15q12-13.1 CAU HERC2 2,261 2,546 0.89 0.02 40.05 Jin et al. (2012)
16q24.3 CAU MC1R 1,551 2,565 0.59 0.00 40.05 Jin et al. (2012)
22q13.2 CAU TOB2 3,886 3,959 0.98 0.58 40.05 Jin et al. (2012)
22q12.3 CAU C1QTNF6 651 818 0.84 0.02 40.05 Jin et al. (2010a)
21q22.3 CAU UBASH3A 80 78 1.03 0.77 40.05 Jin et al. (2010a)
Abbreviations: CAU, Caucasian; CHI, Chinese; GWAS, genome-wide association study; Vit LS, vitiligo lesional skin; Vit NS, vitiligo perilesional normal skin.
*P-value using paired Student t-test was used to calculate the statistical significance before correction for multiple testing.
**P-value after multiple testing with Bonferroni method using GeneSpring GX7.3 software.
Characters written in bold indicate that genes had significantly different expression.
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lupus erythematosus, and ulcerative colitis; Supplementary Table S2
online) and summarized the previously reported susceptibility loci
for these autoimmune diseases. Using HapMap data, we then
searched the LD blocks tagged by these reported top SNPs for related
autoimmune diseases and then identified the top SNPs in these
blocks from our own vitiligo GWAS for further replication (For
European GWAS results, we defined the LD block based on the CEU
panel in HapMap 2 and 3; for Asian GWAS result, analyses were
based on JPT and CHB panels of HapMap 2 and on CHB, CHD, JPT
panels of HapMap 3). All the SNPs in the LD block have r2X0.2 with
the top SNPs, and we constrained LD blocks to 500 kb. A total of 26
SNPs in 25 autoimmune disease loci that showed nominal evidence
of association (Pinitialo0.05) in our vitiligo GWAS were selected for
replication (Supplementary Table S3 online). Finally, we selected
five SNPs (Pinitialo0.05) from four vitiligo susceptibility loci
previously reported in the Caucasian population (Jin et al., 2010a)
to determine whether these loci also constitute vitiligo susceptibility
loci in the Chinese population (Supplementary Table S4 online).
Genotyping and quality control
DNA preparation, genome-wide genotyping using the Illumina 610-
Quad BeadChip (Illumina, San Diego, CA) and replication genotyp-
ing using the Sequenom MassArray iPLEX system (Sequenom, San
Diego, CA), and quality control filtering of the data have been
described previously (Quan et al., 2010).
Statistical analysis
Both the genome-wide and replication analyses were carried out
using PLINK version 1.07. (Purcell et al., 2007). The quantile–quan-
tile plot and genomic inflation factor were calculated using the
statistical analysis program R (http://www.r-project.org/), which
evaluated the overall significance of the genome-wide association
results. All statistical results were reported without genomic control
correction, as minimal evidence of population stratification was
found. The data set was additionally assessed for population outlier
and stratification using a principal component analysis–based
approach (Pe’er et al., 2008; Quan et al., 2010). GWAS and
replication analyses were carried out using the Cochran–Armitage
trend test. Calculations of association P-values in the GWAS,
replication 1, replication 2, and combined analyses were made
using two-tailed tests. Recombination plots of each discovered
susceptibility locus were generated using the information from the
HapMap project (CHB and JPT samples). Imputation of SNPs in our
GWAS data was performed using data from the 1000 Genomes
Project by Impute v2.0 (Department of Statistics, University of
Oxford, UK), which was then tested for association.
Skin biopsy transcriptome analysis
RNA samples from 17 pairs of full-thickness vitiligo skin (lesional
and normal perilesional skin) were used in DNA microarray analysis
following a previously described protocol (Wang et al., 2011; Zhang
et al., 2012). In brief, total cellular RNA (500 ng) was reverse-
transcribed into complementary DNA and linearly amplified by
in vitro transcription in the presence of fluorescent-labeled CTP
using the Low RNA Input Linear Amplification Kit, PLUS, Two-Color,
from Agilent (Agilent Technologies, Santa Clara, CA) following the
manufacturer’s instructions. Each microarray was hybridized with
825 ng of each amplified complementary DNA labeled with Cy5 or
Cy3 at a specific activity between 8 and 15 pmol mg1. Hybridiza-
tions were performed on Whole Human Genome Oligo microarrays
(G4112F, Agilent Technologies), comprising 41,059 60-nucleotide
oligonucleotide probes, mostly represented as single spots. Image
scanning was performed using the Agilent DNA Microarray Scanner
and quantified using Agilent’s Feature Extraction software. The
results were imported and analyzed with GeneSpring GX 7.3
software (Agilent Technologies) for statistical computation and
visualization. Data normalization was performed within and across
the arrays using per-gene, per-chip normalization according to the
Agilent recommendation. To present the differentially expressed
genes between vitiligo lesional skin and perilesional normal skin
from patients with vitiligo, paired Student t-tests were used to
calculate the statistical significance of any expression difference
found. The genes were ranked according to their false discovery
rate–adjusted P-values and a cutoff of Po0.05 (Bonferroni correction
was used to control for multiple testing).
Nonsynonymous SNP analysis
Data from the 1000 Genomes Project March 2010 release (see URLs,
http://www.1000genomes.org/) were used to find nonsynonymous,
splice, or stop-encoding SNPs in high LD (r2X0.5).
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